228 related articles for article (PubMed ID: 3492208)
1. Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus.
Lockshin MD; Qamar T; Redecha P; Harpel PC
Arthritis Rheum; 1986 Dec; 29(12):1467-72. PubMed ID: 3492208
[TBL] [Abstract][Full Text] [Related]
2. Lupus pregnancy. II. Unusual pattern of hypocomplementemia and thrombocytopenia in the pregnant patient.
Lockshin MD; Harpel PC; Druzin ML; Becker CG; Klein RF; Watson RM; Elkon KB; Reinitz E
Arthritis Rheum; 1985 Jan; 28(1):58-66. PubMed ID: 3917671
[TBL] [Abstract][Full Text] [Related]
3. Alternative complement pathway in hypocomplementemic/normal C1s-C1 inhibitor complex patients with SLE.
Levy RA; Qamar T; Lockshin MD
Clin Exp Rheumatol; 1990; 8(1):11-5. PubMed ID: 2347130
[TBL] [Abstract][Full Text] [Related]
4. Complement components, C1 activation and disease activity in SLE.
Sturfelt G; Sjöholm AG; Svensson B
Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
[TBL] [Abstract][Full Text] [Related]
5. Complement components, complement activation, and acute phase response in systemic lupus erythematosus.
Sturfelt G; Sjöholm AG
Int Arch Allergy Appl Immunol; 1984; 75(1):75-83. PubMed ID: 6086533
[TBL] [Abstract][Full Text] [Related]
6. In vitro stimulation of C1s proteolytic activities by C1s-presenting autoantibodies from patients with systemic lupus erythematosus.
He S; Lin YL
J Immunol; 1998 May; 160(9):4641-7. PubMed ID: 9574573
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of (C1INH)2 C1r-C1s complexes in glomerulonephritis as an indicator of C1 activation.
Waldo FB; West CD
Clin Immunol Immunopathol; 1987 Feb; 42(2):239-49. PubMed ID: 3026704
[TBL] [Abstract][Full Text] [Related]
8. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
9. [Immune complex and complement levels in spontaneous abortions and normal pregnancy].
Saitoh S; Nakanishi A; Ichijo M
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):1981-90. PubMed ID: 6607297
[TBL] [Abstract][Full Text] [Related]
10. Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosus.
Jonsson H; Sturfelt G; Mårtensson U; Truedsson L; Sjöholm AG
Clin Exp Rheumatol; 1995; 13(5):573-80. PubMed ID: 8575134
[TBL] [Abstract][Full Text] [Related]
11. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE).
Lloyd W; Schur PH
Medicine (Baltimore); 1981 May; 60(3):208-17. PubMed ID: 7231154
[TBL] [Abstract][Full Text] [Related]
12. Complement profile in a C1 inhibitor deficient family.
Sayama K; Shiraishi S; Miki Y
Br J Dermatol; 1985 Dec; 113(6):737-43. PubMed ID: 4096884
[TBL] [Abstract][Full Text] [Related]
13. Detection of immune complexes in systemic lupus erythematosus with the C1q solid phase assay: correlation with nDNA antibodies and hypocomplementemia.
Agnello V; Mitamura T
Clin Immunol Immunopathol; 1987 Mar; 42(3):338-43. PubMed ID: 3493866
[TBL] [Abstract][Full Text] [Related]
14. [Components of the classical complement pathway in systemic lupus erythematosus].
Maillet F; Goetz J; Hauptmann G; Clauvel JP; Mery JP; Kahn MF; Kazatchkine M
Presse Med; 1987 Mar; 16(8):378-82. PubMed ID: 2950498
[TBL] [Abstract][Full Text] [Related]
15. C1 inactivator-C1s complexes in inflammatory joint disease.
Inman RD; Harpel PC
Clin Exp Immunol; 1983 Sep; 53(3):521-8. PubMed ID: 6604603
[TBL] [Abstract][Full Text] [Related]
16. Sequential studies of complement activation in systemic lupus erythematosus.
Sturfelt G; Johnson U; Sjöholm AG
Scand J Rheumatol; 1985; 14(2):184-96. PubMed ID: 4001891
[TBL] [Abstract][Full Text] [Related]
17. Circulating immune complexes and C1 activation in patients with rapidly progressive glomerulonephritis, before and after treatment with immunosuppression and plasma exchange.
Sjöholm AG; Brun C; Larsen S; Thysell H
Int Arch Allergy Appl Immunol; 1983; 72(1):9-15. PubMed ID: 6874103
[TBL] [Abstract][Full Text] [Related]
18. Disease states in genetic complement deficiencies.
Tappeiner G
Int J Dermatol; 1982 May; 21(4):175-91. PubMed ID: 6284665
[No Abstract] [Full Text] [Related]
19. Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay.
Nilsson T; Bäck O
Clin Exp Immunol; 1985 Apr; 60(1):178-82. PubMed ID: 3874014
[TBL] [Abstract][Full Text] [Related]
20. Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus.
Miyawaki Y; Sada K; Asano Y; Hayashi K; Yamamura Y; Hiramatsu S; Ohashi K; Morishita M; Watanabe H; Matsumoto Y; Kawabata T; Wada J
Lupus; 2018 Nov; 27(13):2093-2100. PubMed ID: 30309286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
